# Florbetaben for Imaging of Vascular Amyloid

> **NCT06091319** · — · RECRUITING · sponsor: **Ottawa Heart Institute Research Corporation** · enrollment: 30 (estimated)

## Conditions studied

- Acute Coronary Syndrome
- Stroke
- Transient Ischemic Attack
- Atherosclerosis of Artery

## Interventions

- **PROCEDURE:** [18F]-Florbetaben PET and CT imaging

## Key facts

- **NCT ID:** NCT06091319
- **Lead sponsor:** Ottawa Heart Institute Research Corporation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-09
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06091319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06091319, "Florbetaben for Imaging of Vascular Amyloid". Retrieved via AI Analytics 2026-09-01 from https://api.ai-analytics.org/clinical/NCT06091319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*